Investors bet heavily on AI in mid-2026, putting more than 70% of global venture capital into it in Q2 2026 and 64% in Q3. Here in Canada, Beacon Software raised US$225 million to buy small software companies and rebuild them with AI. Biossil, which uses AI to revive failed drug candidates, became a unicorn after a US$153 million round. Plus AI for cancer trials, tunnel construction, health clinics and more.
Click below to view our spotlight of the standout Canadian AI deals announced in Q2 and Q3 2026.